Austrian consensus statement on the diagnosis and management of hypertrophic cardiomyopathy.
Verheyen, N, Auer, J, Bonaros, N, Buchacher, T, Dalos, D, Grimm, M et al.. Wien Klin Wochenschr. 2024; 136 (Suppl 15):571-597. doi: 10.1007/s00508-024-02442-1. PubMed PMID:39352517 PubMed Central PMC11445290.
Editorial comment regarding article: Incremental prognostic utility of congestion markers in cardiac transthyretin amyloidosis.
Verheyen, N, Rainer, PP. Clin Res Cardiol. 2024; :. doi: 10.1007/s00392-024-02528-w. PubMed PMID:39222278 .
Bone morphogenic protein-4 availability in the cardiac microenvironment controls inflammation and fibrosis in autoimmune myocarditis.
Perez-Shibayama, C, Gil-Cruz, C, Cadosch, N, Lütge, M, Cheng, HW, De Martin, A et al.. Nat Cardiovasc Res. 2024; 3 (3):301-316. doi: 10.1038/s44161-024-00432-0. PubMed PMID:39196111 PubMed Central PMC11358008.
Differences in heart failure with preserved ejection fraction management between care providers: an international survey.
Guidetti, F, Giraldo, CIS, Shchendrygina, A, Kida, K, Niederseer, D, Basic, C et al.. Eur J Heart Fail. 2024; :. doi: 10.1002/ejhf.3416. PubMed PMID:39169613 .
The Association Between Inflammatory Cell Response and Change in Infarct Size Following STEMI.
Lim, J, Moir, S, Collins, N, Hardy, S, Mabotuwana, N, Sugito, S et al.. JACC Adv. 2023; 2 (9):100660. doi: 10.1016/j.jacadv.2023.100660. PubMed PMID:38938737 PubMed Central PMC11198135.
Predictors and Risk Score for Immune Checkpoint-Inhibitor-Associated Myocarditis Severity.
Power, JR, Dolladille, C, Ozbay, B, Procureur, AM, Ederhy, S, Palaskas, NL et al.. medRxiv. 2024; :. doi: 10.1101/2024.06.02.24308336. PubMed PMID:38883792 PubMed Central PMC11177901.
Exploring T Cell Receptor Repertoires in Myocardial Diseases.
Ashour, D, Le Gouge, K, Rainer, PP, Mariotti-Ferrandiz, E, Campos Ramos, G. Circ Res. 2024; 134 (12):1808-1823. doi: 10.1161/CIRCRESAHA.124.323661. PubMed PMID:38843289 .
Mechanisms of myocardial reverse remodelling and its clinical significance: A scientific statement of the ESC Working Group on Myocardial Function.
Falcão-Pires, I, Ferreira, AF, Trindade, F, Bertrand, L, Ciccarelli, M, Visco, V et al.. Eur J Heart Fail. 2024; 26 (7):1454-1479. doi: 10.1002/ejhf.3264. PubMed PMID:38837573 .
Phenotype clustering of hospitalized high-risk patients with COVID-19 - a machine learning approach within the multicentre, multinational PCHF-COVICAV registry.
Sokolski, M, Trenson, S, Reszka, K, Urban, S, Sokolska, JM, Biering-Sørensen, T et al.. Cardiol J. 2024; 31 (4):512-521. doi: 10.5603/cj.98489. PubMed PMID:38832553 PubMed Central PMC11374323.
A roadmap for therapeutic discovery in pulmonary hypertension associated with left heart failure. A scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Working Group on Pulmonary Circulation & Right Ventricular Function.
Ameri, P, Mercurio, V, Pollesello, P, Anker, MS, Backs, J, Bayes-Genis, A et al.. Eur J Heart Fail. 2024; 26 (4):707-729. doi: 10.1002/ejhf.3236. PubMed PMID:38639017 PubMed Central PMC11182487.
The Prognostic Value of Right Ventricular Function in Patients with Chronic Heart Failure-A Prospective Study.
Schwegel, N, Zach, D, Peikert, A, Santner, V, Höller, V, Gollmer, J et al.. J Clin Med. 2024; 13 (7):. doi: 10.3390/jcm13071930. PubMed PMID:38610695 PubMed Central PMC11012981.
Cerebral white matter hyperintensities indicate severity and progression of coronary artery calcification.
Kneihsl, M, Gattringer, T, Hofer, E, Rainer, PP, Ranner, G, Fandler-Höfler, S et al.. Sci Rep. 2024; 14 (1):4664. doi: 10.1038/s41598-024-55305-0. PubMed PMID:38409473 PubMed Central PMC10897190.
Changes in cardiac troponins during hemodialysis depend on hemodialysis membrane and modality: a randomized crossover trial.
Kolland, M, Amenitsch, J, Schreiber, N, Ginthör, N, Schuller, M, Riedl, R et al.. Clin Kidney J. 2024; 17 (1):sfad297. doi: 10.1093/ckj/sfad297. PubMed PMID:38213495 PubMed Central PMC10783248.
Extracellular Matrix Protein-1 as a Mediator of Inflammation-Induced Fibrosis After Myocardial Infarction.
Hardy, SA, Liesinger, L, Patrick, R, Poettler, M, Rech, L, Gindlhuber, J et al.. JACC Basic Transl Sci. 2023; 8 (12):1539-1554. doi: 10.1016/j.jacbts.2023.05.010. PubMed PMID:38205347 PubMed Central PMC10774582.
Low-grade systemic inflammation and left ventricular dysfunction in hypertensive compared to non-hypertensive hypertrophic cardiomyopathy.
Zach, DK, Schwegel, N, Santner, V, Winkelbauer, L, Hoeller, V, Kolesnik, E et al.. Int J Cardiol. 2024; 399 :131661. doi: 10.1016/j.ijcard.2023.131661. PubMed PMID:38158132 .
Acute heart failure: mechanisms and pre-clinical models-a Scientific Statement of the ESC Working Group on Myocardial Function.
Ciccarelli, M, Pires, IF, Bauersachs, J, Bertrand, L, Beauloye, C, Dawson, D et al.. Cardiovasc Res. 2023; 119 (14):2390-2404. doi: 10.1093/cvr/cvad088. PubMed PMID:37967390 .
Fibulin-3 is necessary to prevent cardiac rupture following myocardial infarction.
Murtha, LA, Hardy, SA, Mabotuwana, NS, Bigland, MJ, Bailey, T, Raguram, K et al.. Sci Rep. 2023; 13 (1):14995. doi: 10.1038/s41598-023-41894-9. PubMed PMID:37696945 PubMed Central PMC10495317.
Non-eligibility for pivotal HFpEF/HFmrEF outcome trials and mortality in a contemporary heart failure cohort.
Santner, V, Riepl, HS, Posch, F, Wallner, M, Rainer, PP, Ablasser, K et al.. Eur J Intern Med. 2023; 118 :73-81. doi: 10.1016/j.ejim.2023.07.027. PubMed PMID:37517939 .
The value of clinical routine blood biomarkers in predicting long-term mortality after stroke.
Hatab, I, Kneihsl, M, Bisping, E, Rainer, PP, Fandler-Höfler, S, Eppinger, S et al.. Eur Stroke J. 2023; 8 (2):532-540. doi: 10.1177/23969873231162125. PubMed PMID:37231701 PubMed Central PMC10334163.
Evaluation of Autoantibody Binding to Cardiac Tissue in Multisystem Inflammatory Syndrome in Children and COVID-19 Vaccination-Induced Myocarditis.
Patel, H, Sintou, A, Chowdhury, RA, Rothery, S, Iacob, AO, Prasad, S et al.. JAMA Netw Open. 2023; 6 (5):e2314291. doi: 10.1001/jamanetworkopen.2023.14291. PubMed PMID:37200028 PubMed Central PMC10196878.